WO2019045259A2 - 철피석곡 꽃 추출물을 포함하는 화장료 조성물 - Google Patents
철피석곡 꽃 추출물을 포함하는 화장료 조성물 Download PDFInfo
- Publication number
- WO2019045259A2 WO2019045259A2 PCT/KR2018/007832 KR2018007832W WO2019045259A2 WO 2019045259 A2 WO2019045259 A2 WO 2019045259A2 KR 2018007832 W KR2018007832 W KR 2018007832W WO 2019045259 A2 WO2019045259 A2 WO 2019045259A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- present
- extract
- cosmetic composition
- composition
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 126
- 239000000203 mixture Substances 0.000 title claims abstract description 103
- 239000002537 cosmetic Substances 0.000 title claims abstract description 42
- 241000026010 Dendrobium candidum Species 0.000 title claims abstract description 17
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 45
- 230000002087 whitening effect Effects 0.000 claims abstract description 41
- 230000037303 wrinkles Effects 0.000 claims abstract description 39
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000004480 active ingredient Substances 0.000 claims abstract description 27
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 26
- 235000013305 food Nutrition 0.000 claims abstract description 25
- 108010035532 Collagen Proteins 0.000 claims abstract description 18
- 102000008186 Collagen Human genes 0.000 claims abstract description 18
- 229920001436 collagen Polymers 0.000 claims abstract description 18
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 18
- 239000003814 drug Substances 0.000 claims abstract description 14
- 229940079593 drug Drugs 0.000 claims abstract description 13
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 8
- 230000005764 inhibitory process Effects 0.000 claims description 13
- 241001523681 Dendrobium Species 0.000 claims description 2
- 230000006872 improvement Effects 0.000 abstract description 26
- 230000002401 inhibitory effect Effects 0.000 abstract description 16
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 134
- 238000004519 manufacturing process Methods 0.000 description 65
- 238000002360 preparation method Methods 0.000 description 48
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 28
- 230000000694 effects Effects 0.000 description 25
- 210000004027 cell Anatomy 0.000 description 21
- 238000000034 method Methods 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 14
- 206010061218 Inflammation Diseases 0.000 description 13
- 238000009472 formulation Methods 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 13
- 230000004054 inflammatory process Effects 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 239000012676 herbal extract Substances 0.000 description 11
- 239000013642 negative control Substances 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 241000207929 Scutellaria Species 0.000 description 9
- 230000014509 gene expression Effects 0.000 description 9
- 235000013376 functional food Nutrition 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 239000013641 positive control Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 229910052742 iron Inorganic materials 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- NTNWOCRCBQPEKQ-YFKPBYRVSA-N N(omega)-methyl-L-arginine Chemical compound CN=C(N)NCCC[C@H](N)C(O)=O NTNWOCRCBQPEKQ-YFKPBYRVSA-N 0.000 description 6
- 244000184734 Pyrus japonica Species 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 210000002950 fibroblast Anatomy 0.000 description 6
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 244000247747 Coptis groenlandica Species 0.000 description 5
- 235000002991 Coptis groenlandica Nutrition 0.000 description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 5
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 5
- 244000291564 Allium cepa Species 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 102000012422 Collagen Type I Human genes 0.000 description 4
- 108010022452 Collagen Type I Proteins 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000011425 bamboo Substances 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 239000002158 endotoxin Substances 0.000 description 4
- -1 fatty acid esters Chemical class 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 229920006008 lipopolysaccharide Polymers 0.000 description 4
- 230000008099 melanin synthesis Effects 0.000 description 4
- 201000001441 melanoma Diseases 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 208000017520 skin disease Diseases 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 3
- 235000017491 Bambusa tulda Nutrition 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000255789 Bombyx mori Species 0.000 description 3
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 208000010201 Exanthema Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- 244000082204 Phyllostachys viridis Species 0.000 description 3
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 3
- 238000011529 RT qPCR Methods 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229960000271 arbutin Drugs 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 201000005884 exanthem Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 108090000672 Annexin A5 Proteins 0.000 description 2
- 102000004363 Aquaporin 3 Human genes 0.000 description 2
- 108090000991 Aquaporin 3 Proteins 0.000 description 2
- 244000178993 Brassica juncea Species 0.000 description 2
- 235000011332 Brassica juncea Nutrition 0.000 description 2
- 235000014700 Brassica juncea var napiformis Nutrition 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 238000011891 EIA kit Methods 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- 241000222336 Ganoderma Species 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108090000320 Hyaluronan Synthases Proteins 0.000 description 2
- 102100040206 Hyaluronan synthase 2 Human genes 0.000 description 2
- 102100029425 Hyaluronan synthase 3 Human genes 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 208000035150 Hypercholesterolemia Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- CNBGNNVCVSKAQZ-UHFFFAOYSA-N benzydamine Chemical compound C12=CC=CC=C2C(OCCCN(C)C)=NN1CC1=CC=CC=C1 CNBGNNVCVSKAQZ-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000001465 calcium Nutrition 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
- 210000000224 granular leucocyte Anatomy 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000003061 melanogenesis Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 235000020637 scallop Nutrition 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000032841 Bulimia Diseases 0.000 description 1
- 206010006550 Bulimia nervosa Diseases 0.000 description 1
- 108010075254 C-Peptide Proteins 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 244000030990 Dendrobium fimbriatum Species 0.000 description 1
- 241000229499 Dendrobium loddigesii Species 0.000 description 1
- 240000004638 Dendrobium nobile Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015226 Erythema nodosum Diseases 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 102100023593 Fibroblast growth factor receptor 1 Human genes 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 240000000455 Holodiscus discolor Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000827746 Homo sapiens Fibroblast growth factor receptor 1 Proteins 0.000 description 1
- 101000917159 Homo sapiens Filaggrin Proteins 0.000 description 1
- 101710197056 Hyaluronan synthase 2 Proteins 0.000 description 1
- 101710197055 Hyaluronan synthase 3 Proteins 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000010931 Mesua ferrea Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000005704 Olneya tesota Nutrition 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 241000237509 Patinopecten sp. Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 241000237503 Pectinidae Species 0.000 description 1
- 201000011152 Pemphigus Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 108010050808 Procollagen Proteins 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 235000008198 Prosopis juliflora Nutrition 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 238000011530 RNeasy Mini Kit Methods 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010053262 Skin swelling Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 241000219995 Wisteria Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229910000063 azene Inorganic materials 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960000333 benzydamine Drugs 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229960004369 flufenamic acid Drugs 0.000 description 1
- LPEPZBJOKDYZAD-UHFFFAOYSA-N flufenamic acid Chemical compound OC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 LPEPZBJOKDYZAD-UHFFFAOYSA-N 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000003633 gene expression assay Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 201000001976 pemphigus vulgaris Diseases 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 238000004161 plant tissue culture Methods 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000008234 soft water Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Definitions
- the present invention relates to a cosmetic composition comprising a Dendrobium candidum flower extract, and more particularly to a cosmetic composition having an excellent skin improving effect such as wrinkle improvement, skin whitening, skin trouble improvement, skin moisturizing and the like.
- the present invention relates to a quasi-drug composition and a food composition containing a hydroxycarboxylic acid flower extract.
- Collagen is a major substrate protein produced in the fibroblasts of the skin and exists in extracellular epilepsy. Its important functions are mechanical durability of the skin, resistance of connective tissues and binding force of tissues, support of cell adhesion, cell division and differentiation (Induction of growth of an organism or wound healing) are known. Such collagen is reduced by photoaging by age and ultraviolet irradiation, and collagenase activity, which degrades collagen, promotes collagen reduction. This is known to be closely related to the formation of wrinkles in the skin.
- retinoids adenosine, animal placenta-derived proteins, chlorella extract, and the like are known as cosmetics for improving skin elasticity and improving wrinkles.
- the best known retinol is a substance that promotes collagen synthesis and inhibits elastase enzyme.
- retinol is a substance that promotes collagen synthesis and inhibits elastase enzyme.
- retinol when applied to the skin, there is a limitation in usage due to safety problems such as irritation and redness, and chlorella extract has little effect, And it is known that it is difficult to expect a wrinkle-reducing effect.
- Commonly known whitening ingredients include substances inhibiting tyrosinase enzyme activity such as kojic acid or arbutin, hydroquinone, vitamin C (L-ascorbic acid) or derivatives thereof, various plant extracts .
- tyrosinase enzyme activity such as kojic acid or arbutin, hydroquinone, vitamin C (L-ascorbic acid) or derivatives thereof, various plant extracts .
- melanin pigment By inhibiting the synthesis of melanin pigment, they can brighten the skin tone to realize skin whitening, and it is possible to improve skin hypercholesterolemia such as stain or freckles due to ultraviolet rays, hormones or heredity.
- the use amount is limited due to safety problems such as irritation and redness, or the effect is insignificant, so that a practical effect can not be expected.
- Cosmetics are products used to protect the skin and beautify and clean the skin, but the composition thereof inevitably includes ingredients that are different from the purpose of skin protection. These ingredients include surfactants, preservatives, fragrances, sunscreens, pigments, as well as various ingredients for imparting other efficacy and effects. These ingredients are generally known to cause skin irritation, rashes, swelling and other problems (Maibach, H., I. Contact Dermatitis, 6. 369-404, 1980). In addition, sebum and sweat discharged from the body, fatty acids in cosmetic ingredients, higher alcohols, protein components and the like may be decomposed into substances having high toxicity by the skin-on-ground bacteria existing on the skin, It is well known that skin inflammation is caused by ultraviolet rays from the sun.
- Inflammation reactions are manifested in five phenomena, such as feeling of redness, pricking feeling, burning hotness, swelling, and tissue changes, which may be caused by harmful environmental conditions, It is a physiological reaction to protect a living body from intrusion and mechanical damage.
- These inflammatory phenomena lead to a large number of polymorphonuclear leukocytes (PMNs) and immune substances, and these increased cells secrete a variety of inflammatory cell products, proteases and cytokines. I can do it.
- PMNs polymorphonuclear leukocytes
- I can do it.
- this action may cause harmful damage to adjacent tissue cells and non-cellular components. Therefore, under proper conditions, the normal function is restored after the initial state of inflammation.
- irritant stimulating agents are not eliminated or continuously produced, chronic inflammation occurs as a result, resulting in more serious tissue damage.
- the moisturizing cosmetic composition used for the skin has a function of preventing damages such as cracking and drying by making the skin look soft and vivid by keeping a certain amount of water on human hair or skin. That is, the cosmetic composition for moisturizing the skin is used for the purpose of supplying more than a certain amount of water to the skin or hair or keeping the moisture to beautify the skin or hair and keep it healthy. Since the skin is responsible for about 65-70% of the moisture control, studies on the supply, maintenance, and moisturization of water have been actively conducted in the field of cosmetics. Recently, a physiologically active substance obtained from natural products has been introduced into cosmetics, The development of cosmetics that increase the moisturizing power by keeping the function is becoming active.
- Korean Patent Publication No. 2002-0044266 discloses a cosmetic composition for skin protection comprising a complex herbal extract.
- the herbal extract alone and its skin protection effect were not disclosed.
- the inventors of the present invention conducted studies on substances having superior wrinkle, skin whitening, skin trouble improvement, and skin moisturizing effect from natural natural resources. Melanin formation inhibition, antiinflammatory effect, and moisturizing effect as compared with extracts of other parts of cheonggukbok, and the cosmetic composition, quasi-drug composition and food composition using the same were completed.
- An object of the present invention is cheolpi seokgok (Dendrobium candidum ) flower extract as an active ingredient.
- Dendrobium candidum flower extract as an active ingredient.
- Dendrobium candidum flower extract as an active ingredient.
- Dendrobium candidum flower extract as an active ingredient.
- Dendrobium candidum flower extract as an active ingredient.
- the cosmetic composition comprising the herbal composition of the present invention as an active ingredient is excellent in wrinkle, skin whitening, skin trouble, or skin moisturizing effect.
- the composition of the present invention is excellent in the effect of promoting collagen synthesis, inhibiting melanin formation, anti-inflammatory effect, and moisturizing effect and thus being used as a cosmetic composition for improving wrinkles, skin whitening, improving skin troubles, or moisturizing skin.
- the composition comprising the extract of the present invention as an active ingredient can be used as a quasi-drug composition and a food composition.
- the present invention provides a cosmetic composition comprising an extract of Scutellaria japonica as an active ingredient.
- Dendrobium Candidum is one of the Orchidaceae plants widely known as traditional medicinal plants. It is widely distributed in the central and southern part of China and has been widely used for medicinal purposes since ancient times. It has a cylindrical shape with a length of 15 to 50 cm and a diameter of 0.15 to 0.3 cm, between 1 and 4 cm between the nodes, yellow on the outer surface, partly shiny on the lower part, with vertical wrinkles, with inflorescences on the nodules, remaining leaf sheaths, The invention can be used in the form of a commercially sold product, or it can be harvested or cultivated in nature.
- the extracts of Coptis bark, Gingko ginseng, Atoll Golgok, Ganoderma Ganoderma, and Ganoderma Ganoderma were prepared, respectively, and the effect of improving the wrinkle, skin whitening effect, skin trouble, Respectively.
- the above-mentioned skin improving effect was most excellent when using scallops of iron, as compared with other plants belonging to Dendrobii Caulis (Tables 1 to 4).
- the flower part of the scaly gravel as a specific part among the plant parts.
- the present invention it is possible to produce wrinkle-suppressing extract, root extract, stem extract, leaf extract and flower extract, respectively, Respectively. From the results of each experiment, it was confirmed that the skin-improving effect was most excellent when using the extract derived from the flower part of the scaly gill (Fig. 1). Therefore, the present invention is characterized by using a flower part extract even among the scallion of iron and steel.
- the " extract” means an extract obtained by extracting the rice bran, a diluted solution or concentrate of the extract, a dried product obtained by drying the extract, a preparation or a purified product of the extract, Extracts themselves and extracts of all formulations which can be formed using extracts.
- the extract of the present invention can be extracted from natural, hybrid, or variegated plants of iron and bark, and can also be extracted from plant tissue cultures.
- the method for extracting the extract of the present invention is not particularly limited, and extraction can be carried out according to a method commonly used in the art.
- Non-limiting examples of the extraction method include hydrothermal extraction, ultrasonic extraction, filtration, and reflux extraction. These may be performed alone or in combination with two or more methods.
- the kind of the extraction solvent used for extracting the scum is not particularly limited, and any solvent known in the art can be used.
- Non-limiting examples of such extraction solvents include water (or distilled water); C1 to C4 lower alcohols such as methanol, ethanol, propyl alcohol and butyl alcohol; Polyhydric alcohols such as glycerin, butylene glycol and propylene glycol; And hydrocarbon solvents such as methyl acetate, ethyl acetate, acetone, benzene, hexane, diethyl ether, and dichloromethane; (Or distilled water), a lower alcohol, 1,3-butylene glycol and ethyl acetate may be used alone or in admixture of two or more. More specifically, water (or distilled water) Distilled water) can be used.
- a solvent extract may be prepared by extracting the iron scales at least once using the solvent, and the dry extract obtained by vacuum distillation or freeze drying or spray drying the solvent extract may be prepared.
- water or distilled water was used to produce an extract of iron and steel bark (Preparation Examples 1 to 9).
- the present invention provides a cosmetic composition for improving wrinkles, which comprises an extract of a herbal extract of Brassica juncea as an active ingredient.
- wrinkle improvement means suppressing or inhibiting the generation of wrinkles on the skin, or alleviating already formed wrinkles.
- the extract of fibrous soap bloom was added to a culture solution of human fibroblasts to measure the type 1 collagen synthesis ratio at the cell level, (TGF- ⁇ ), and the collagen synthesis effect was equal to or higher than that of the positive control (TGF- ⁇ ) (Table 1).
- the herbaceous flower extract of the present invention can be usefully used for improving wrinkles by promoting collagen synthesis.
- the present invention provides a cosmetic composition for skin whitening comprising an extract of Scutellaria japonica as an active ingredient.
- skin whitening refers to not only brightening the skin tone by inhibiting the synthesis of melanin pigment but also improving skin hypercholesterolemia due to ultraviolet rays, hormones or heredity, such as spots or freckles.
- the total amount of melanin was determined by adding a herbal extract of Brassica juncea to a culture supernatant of rat melanoma cells (B-16). As a result, melanin (Table 2). It was confirmed that the inhibitory effect on the production of melanin was more excellent than that of the positive control (Albutin) (Table 2).
- the herbaceous flower extract of the present invention inhibits melanin production and thus can be usefully used for skin whitening applications.
- the present invention provides a cosmetic composition for improving skin troubles, which comprises an extract of Scutellaria japonica as an active ingredient.
- skin trouble means a skin disease that can be caused by inflammation caused by excessive nitric oxide production in macrophages.
- the skin troubles include all kinds of skin diseases related to inflammation regardless of the type thereof.
- Non-limiting examples of skin diseases related to inflammation include inflammatory diseases caused by atopic dermatitis, psoriasis, radiation, chemical substances, Inflammatory hair loss such as acid burns, bulimia dermatosis, visceral type disease, allergic itching, seborrheic eczema, rose acne, pemphigus vulgaris, polymorphic exudative erythema, erythema nodosum, - cell lymphoma, and the like, and specifically include, but are not limited to, skin rash, acne, rash, injection (red nose).
- improvement of trouble refers to inhibiting or inhibiting the generation of troubles in the skin or alleviating troubles already generated.
- anti-inflammation refers to inhibition of inflammation.
- the inflammation is a defense reaction of biological tissue against a certain stimulus, and includes complicated lesions involving tissue degeneration, circulatory disorder and exudation, and tissue proliferation. It says. More specifically, inflammation is part of congenital immunity and, like in other animals, human congenital immunity recognizes a pattern of cell surfaces that are specifically present in a pathogen. Phagocytes recognize cells with such surfaces as non-magnetic and attack pathogens. If pathogens break through the physical barriers of the body, an inflammatory reaction occurs. Inflammation is a nonspecific defense that creates hostile environments for microorganisms entering the wound.
- the antiinflammation of the present invention may be to suppress inflammation caused in the skin.
- the nitric oxide (NO) inhibitory effect of the herbal extract was found to be superior to the other herb extracts of other kinds of scales (L-NMMA) than the control (L-NMMA) (Table 3).
- the herbaceous perennial flower extract of the present invention inhibits the production of NO, and thus can be usefully used for improving skin troubles.
- the present invention provides a cosmetic composition for moisturizing the skin, which comprises an extract of Celadon flower as an active ingredient.
- skin moisturizing means increasing moisture in the skin and maintaining a moist state. Skin moisturizing effect can help to improve wrinkles and elasticity of skin.
- the moisturizing gene-expressing effect of the herbal extract was found to be higher than that of other herbal extracts of other kinds of scallion and scallop (Table 4 ).
- the herbaceous flower extract of the present invention promotes the expression of a moisturizing gene, and thus can be usefully used for moisturizing skin.
- the wooly gravel of the present invention has the best wrinkle improving effect, skin whitening effect, skin trouble improving effect, and skin moisturizing effect as compared with other kinds of gravel.
- the cosmetic composition according to the present invention can be used as a cosmetic composition in the form of a solution, an ointment for external use, a cream, a foam, a nutritional lotion, a softening water, a pack, a soft water, an emulsion, a makeup base, But are not limited to, emulsions, emulsions, pastes, gels, lotions, powders, soaps, surfactant-containing cleansing, oils, powder foundations, emulsion foundations, wax foundations, patches and sprays Do not.
- the cosmetic composition of the present invention may further comprise at least one cosmetically acceptable carrier to be incorporated in a general skin cosmetic composition, and examples thereof include oil, water, a surfactant, a moisturizer, A thickener, a chelating agent, a coloring matter, an antiseptic, a flavoring, and the like may be appropriately compounded, but the present invention is not limited thereto.
- the cosmetically acceptable carrier to be contained in the cosmetic composition of the present invention varies depending on the formulations.
- the carrier component may be an animal oil, a vegetable oil, a wax, a paraffin, a starch, a tracer, a cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, zinc oxide Mixtures of these may be used.
- lactose When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, polyamide powder or a mixture thereof may be used as the carrier component, Propellants such as fluorohydrocarbons, propane / butane or dimethyl ether.
- a solvent, a dissolving agent or an emulsifying agent is used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, 1,3-butyl glycol oil may be used, in particular fatty acid esters of cottonseed oil, peanut oil, corn oil, olive oil, castor oil and sesame oil, glycerol aliphatic esters, polyethylene glycols or sorbitan may be used have.
- the formulation of the present invention is a suspension
- a carrier such as water, a liquid diluent such as ethanol or propylene glycol, a suspension such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Crystalline cellulose, aluminum metahydroxide, bentonite, agar or tracant, etc. may be used.
- the formulation of the present invention is a soap, an alkali metal salt of a fatty acid, a fatty acid hemiester salt, a fatty acid protein hydrolizate, isethionate, a lanolin derivative, an aliphatic alcohol, a vegetable oil, glycerol, .
- a quasi-drug composition comprising a hydroxycarboxylic acid flower extract as an active ingredient.
- the present invention provides a quasi-product composition for improving wrinkles, skin whitening, improving skin troubles, or skin moisturizing, which comprises an extract of Fusarium oxysporum as an active ingredient.
- the herbaceous flower extract of the present invention wrinkle improvement, skin whitening, skin trouble improvement, skin moisturization are as described above.
- the quasi-drug composition of the present invention may further contain a pharmaceutically acceptable carrier, excipient or diluent as necessary in addition to the above components.
- a pharmaceutically acceptable carrier, excipient or diluent is not limited as long as the effect of the present invention is not impaired, and examples thereof include fillers, extenders, binders, wetting agents, disintegrants, surfactants, lubricants, sweeteners, .
- Representative examples of the pharmaceutically acceptable carrier, excipient or diluent of the present invention include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, maltitol, starch, gelatin, glycerin, acacia rubber, alginate, calcium phosphate, calcium Methyl cellulose, polyvinyl pyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate, mineral oil, propylene glycol, polyethylene glycol, vegetable oils such as sodium carboxymethylcellulose, , Injectable ester, witepsol, macrogol, tween 61, cacao paper, and laurie paper.
- the herbal extract of the present invention when used as a quasi-drug, it may further contain one or more active ingredients exhibiting the same or similar functions.
- it may contain known wrinkle improvement, skin whitening, skin trouble improvement, skin moisturizing ingredients. If wrinkle improvement, skin whitening, skin trouble improvement, and skin moisturizing ingredients are included, wrinkle improvement, skin whitening, skin trouble improvement and skin moisturizing effect of the composition of the present invention can be further increased.
- skin safety, easiness of formulation, and stability of effective ingredients can be considered according to the combined use.
- the quasi-drug composition includes retinoic acid, TGF, an animal placenta-derived protein, betulinic acid and chlorella extract, skin elasticity, wrinkle-improving or moisturizing ingredients well known in the art;
- anti-inflammatory ingredients known in the art there are non-steroid based flufenamic acid, ibuprofen, benzydamine, indomethacin, prednisolone, dexamethasone, allantoin, azene, hydrocortisone; And derivatives thereof, and various plant extracts.
- the additional component may be included in an amount of 0.0001 to 10% by weight based on the total weight of the composition, and the content may be adjusted according to requirements such as skin safety, easiness of formulation of the herbal composition of the present invention will be.
- the quasi-drug composition of the present invention can be exemplified by a disinfectant cleaner, a shower foam, a softener solution, a wet tissue, a coating agent, and the like.
- a disinfectant cleaner a shower foam
- a softener solution a wet tissue
- a coating agent a coating agent
- a food composition comprising an extract of Scutellaria japonica as an active ingredient.
- the present invention provides a food composition for improving wrinkles, whitening skin, improving skin troubles, or moisturizing the skin, which comprises an extract of wilted sheath flower as an active ingredient.
- the herbaceous flower extract of the present invention wrinkle improvement, skin whitening, skin trouble improvement, skin moisturization are as described above.
- the herbaceous perennial flower extract contained in the food composition of the present invention may be contained in the form of an animal, plant extract, an extract thereof, a fraction thereof, or a processed product thereof, which contains the herbal composition of the present invention.
- the composition may also include a food-acceptable food-aid additive in addition to the active ingredient.
- the term "food-aid additive" means a component that can be added to foods in a supplementary manner, and is appropriately selected and used by those skilled in the art as added to produce health functional foods of each formulation.
- food-aid additives include flavors such as various nutrients, vitamins, minerals (electrolytes), synthetic flavors and natural flavors, colorants and fillers, pectic acid and its salts, alginic acid and its salts, organic acids, , a pH adjusting agent, a stabilizer, a preservative, a glycerin, an alcohol, and a carbonating agent used in a carbonated drink.
- flavors such as various nutrients, vitamins, minerals (electrolytes), synthetic flavors and natural flavors, colorants and fillers, pectic acid and its salts, alginic acid and its salts, organic acids, , a pH adjusting agent, a stabilizer, a preservative, a glycerin, an alcohol, and a carbonating agent used in a carbonated drink.
- a health functional food may be included in the food composition of the present invention.
- the term “health functional food” refers to a food prepared and processed in the form of tablets, capsules, powders, granules, liquids and rings using raw materials and components having useful functions in the human body.
- the term “functional” as used herein means that the structure and function of the human body have a beneficial effect on health uses such as controlling nutrients or physiological actions.
- the health functional food of the present invention can be prepared by a method commonly used in the art and can be prepared by adding raw materials and ingredients that are conventionally added in the art.
- the formulation of the dietary supplement is also formulated to be recognized as a dietary supplement can be made without limitation.
- the food composition of the present invention can be manufactured in various formulations, and unlike general pharmaceuticals, it has an advantage of being free from side effects that may occur when a food is used as a raw material for a long period of time, and is excellent in portability.
- Health functional foods can be supplemented to improve wrinkles, skin whitening, improve skin troubles and improve skin moisturizing effect.
- the form of the health functional food of the present invention is not limited, and may include all foods in the conventional meaning, and may be used in combination with terms known in the art such as functional foods.
- the health functional food of the present invention can be prepared by mixing other suitable auxiliary ingredients, which may be included in food, according to the selection of a person skilled in the art, and known additives.
- suitable auxiliary ingredients which may be included in food, according to the selection of a person skilled in the art, and known additives.
- foods that can be added include dairy products, such as meat, sausage, bread, chocolates, candies, snacks, confectionery, pizza, ramen, other noodles, gums, ice cream, various soups, drinks, tea, Vitamin complex, and the like, and can be prepared by adding to juice, tea, jelly, juice and the like prepared by using the compound represented by the formula (1) according to the present invention as a main component. It also includes foods used as feed for animals.
- the herbal extract of the present invention can be used for improving wrinkles, skin whitening, improving skin troubles, or skin moisturizing methods, including a step of applying the extract to the individual's skin.
- the subject includes, without limitation, mammals including rats, livestock, humans, and the like.
- the present invention provides a wrinkle-improving method, a skin whitening method, a skin trouble-improving method, or a skin moisturizing method, which comprises a step of applying a hydroxycarboxylic acid flower extract to an individual's skin.
- Wrinkle improvement, skin whitening, improvement of skin trouble, skin moisturization, individual are as described above.
- the present invention provides a wrinkle-improving use, a skin whitening use, a skin trouble-improving use, or a skin moisturizing use of a cosmetic composition containing a wilt of a herbal extract.
- the present invention also provides a wrinkle-improving composition, a skin whitening composition, a skin trouble-improving composition, or a skin moisturizing composition for a quasi-drug composition containing a hydroxycarboxylic acid flower extract.
- the present invention provides a wrinkle-improving use, a skin whitening use, a skin trouble improving use, or a skin moisturizing use for a food composition containing a wilt of a herbaceous plant.
- Wrinkle improvement, skin whitening, skin trouble improvement, and skin moisturization are as described above.
- the present invention provides a cosmetic composition for improving wrinkles, a skin whitening cosmetic composition, a cosmetic composition for improving skin trouble, or a method for producing a cosmetic composition for skin moisturizing, which contains a hydroxycarboxylic acid flower extract as an active ingredient.
- the present invention also provides a composition for improving wrinkles, a quasi-skin composition for skin whitening, a quasi-quasi- composition composition for skin trouble improvement, or a quasi-quasi-
- the present invention also provides a wrinkle-improving food composition, a skin whitening food composition, a skin trouble-improving food composition, or a method of producing a skin moisturizing food composition, which comprises a wilted flower extract as an active ingredient.
- Wrinkle improvement, skin whitening, skin trouble improvement, and skin moisturization are as described above.
- Dendrobium candidum (flowers, leaves, stems and roots) was dried, and 200 g of distilled water was added to 100 g of dry weight and extracted at 80 ° C for 3 hours. The obtained extract was filtered with a filter having a pore size of 0.2 ⁇ to prepare a hydrothermal extract.
- the cheolpi seokgok seokgok Atoll (Dendrobium loddigesii ). < / RTI >
- a piece of ironwood is called Dendrobium fimbriatum ) was used instead of the compound of Preparation Example 1.
- the scabbard is made of Dendrobium chrysanthemum ) was replaced with chrysanthum .
- Preparation was carried out in the same manner as in Preparation Example 1, except that the wooly sheep outpost was replaced with a sheep roots.
- the samples obtained in Production Examples 1 to 9 were added to the culture medium of human-derived fibroblasts, Respectively.
- the synthesized collagen was quantitated using a PICP EIA kit (Procollagen Type I C-Peptide Enzyme Immunoassay Kit).
- the sample was added to a culture medium of fibroblasts (DMEM medium) to a final concentration of 0.1% and cultured for 48 hours. Then, the culture solution was taken and the degree of type I collagen synthesis at each concentration was measured with a PICP EIA kit using a spectrophotometer nm.
- the degree of collagen synthesis was measured in the same manner as in the culture medium (negative control) of the untreated fibroblasts and the sample (positive control) supplemented with TGF- ⁇ to a final concentration of 10 ng / ml .
- the collagen synthesis rate (%) was calculated as a ratio of relative collagen production to negative control, and the results are shown in Table 1 below.
- the collagen synthesis rate was the highest when compared with the treatment of the roots, stems or leaf extracts (Preparation Examples 6 to 8) of the iron scales, when the extract derived from the scion flower of Preparation Example (Preparation Example 9) was treated, And it was confirmed that it was even better than that of the outpost extract (Preparation Example 1) of wilt of bark.
- the extract of the herbaceous perennial herb extract effectively promotes the synthesis of collagen as compared with the other herb extracts of other kinds, and the extract of the other parts of the herbaceous perilla, and can be usefully used for improving skin wrinkles.
- Samples of Production Examples 1 to 9 were added to the medium to a final concentration of 0.1% and added to the medium (positive control) to give a sample-untreated medium (negative control) and 100 ppm of albutin (positive control) NORMA cells were cultured for 3 days.
- the amount of melanin was measured by the absorbance of 1 ⁇ 10 6 cells per unit cell, and the inhibition rate of melanin formation (%) was calculated by the total amount of melanin relative to the negative control, and the results are shown in Table 2 below.
- the inhibition rate of melanin formation was the highest in comparison with the treatment of roots, stems or leaf extracts (Preparation Examples 6 to 8) of iron scales, in the case of treating the extract derived from scion flowers (Preparation Example 9) And it was confirmed that it was even better than that of the outpost extract (Preparation Example 1) of wilt of bark.
- hydrothermal herbaceous flower extract effectively inhibited melanogenesis as compared with other extracts of other kinds of gravel, and other parts of the hydrothermal gravel, and thus could be usefully used for skin whitening purposes.
- RAW264.7 cells macrophages of mice
- the medium was replaced with a cell culture medium containing the sample at a final concentration of 0.1%, and 20 ppm of L-NMMA (L-NG-Monomethylarginine), which is a NO-production inhibitor, Respectively.
- LPS Lipopolysaccharide
- the NO production inhibition rate (%) was calculated as a relative ratio of the amount of NO reduced relative to the LPS alone treatment group, and the results are shown in Table 3 below.
- the extracts of Scutellaria japonica have an excellent anti-inflammatory effect by inhibiting NO production effectively as compared with other extracts of other types of scales and other parts of the scutellaria, and can be usefully used for improving skin troubles .
- Human keratinocyte HaCaT was added to each well of a 6-well cell culture plate in an amount of 2 ⁇ 10 5 cells / well.
- DMEM medium Gibco, Dulbecco's Modified Eagle's Medium
- DMEM Fetal bovine serum
- RNA extraction kit RNeasy mini kit, Qiagen, Germany.
- RNA 2.5 ⁇ g was quantified and reverse transcribed using cDNA synthesis kit (PhileKorea, Korea). The reverse transcription reaction was performed using Veriti 96 well Thermal Cycler (Applied Biosystems, USA). 100 ng of the synthesized cDNA was used and TaqMan Universal Master Mix II was used. AQP3, FLG, HAS2 and HAS3 primers (TaqMan® Gene Expression Assays, Thermo Fisher, USA) were amplified using real-time PCR (qRT-PCR) using the StepOnePlus® Real- time PCR System (Applied Biosystems, USA) PCR) was performed.
- qRT-PCR real-time PCR
- StepOnePlus® Real- time PCR System Applied Biosystems, USA
- the mRNA expression level of the treated test group was quantified based on the mRNA expression level of the untreated group negative control group at 1.00, as shown in Table 4 below.
- the extracts of Scutellaria japonica exhibit superior skin moisturizing effects as compared with other extracts of other types of scutellaria and other parts of the scutellaria, and can be usefully used for moisturizing skin.
- the herbal extract of the present invention can be effectively used for compositions for improving wrinkles, for whitening skin, for improving skin troubles, or for moisturizing skin.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
시료 | 흡광도(abs) | 콜라겐 합성률 (%) |
음성대조군 | 1.585 | 0 |
TGF-β (10 ng/ml) | 1.826 | 15.21 |
제조예 1 (0.1%) | 1.763 | 11.23 |
제조예 2 (0.1%) | 1.653 | 4.29 |
제조예 3 (0.1%) | 1.692 | 6.75 |
제조예 4 (0.1%) | 1.617 | 2.02 |
제조예 5 (0.1%) | 1.628 | 2.71 |
제조예 6 (0.1%) | 1.601 | 1.01 |
제조예 7 (0.1%) | 1.723 | 8.71 |
제조예 8 (0.1%) | 1.701 | 7.32 |
제조예 9 (0.1%) | 1.892 | 19.37 |
시료 | 흡광도(abs) | 멜라닌 생성 저해율 (%) |
음성대조군 | 0.652 | 0 |
알부틴 (100ppm) | 0.436 | 33.13 |
제조예 1 (0.1%) | 0.523 | 19.79 |
제조예 2 (0.1%) | 0.615 | 5.67 |
제조예 3 (0.1%) | 0.623 | 4.45 |
제조예 4 (0.1%) | 0.596 | 8.59 |
제조예 5 (0.1%) | 0.633 | 2.91 |
제조예 6 (0.1%) | 0.614 | 5.83 |
제조예 7 (0.1%) | 0.571 | 12.42 |
제조예 8 (0.1%) | 0.581 | 10.89 |
제조예 9 (0.1%) | 0.413 | 36.66 |
시료 | 흡광도(abs) | NO 생성 저해율 (%) |
음성대조군 | 0.043 | - |
LPS처리군 | 0.232 | 0 |
L-NMMA (20ppm) | 0.134 | 51.85 |
제조예 1 (0.1%) | 0.173 | 31.22 |
제조예 2 (0.1%) | 0.213 | 10.05 |
제조예 3 (0.1%) | 0.224 | 4.23 |
제조예 4 (0.1%) | 0.199 | 17.46 |
제조예 5 (0.1%) | 0.217 | 7.94 |
제조예 6 (0.1%) | 0.219 | 6.88 |
제조예 7 (0.1%) | 0.181 | 26.98 |
제조예 8 (0.1%) | 0.195 | 19.58 |
제조예 9 (0.1%) | 0.131 | 53.44 |
시료 | 아쿠아포린 3(Aquaporin 3)(fold) | 히아루론산 합성 효소 2(Hyaluronic acid synthase 2)(fold) | 히아루론산 합성 효소 3(Hyaluronic acid synthase 3)(fold) |
음성대조군 | 1.00 | 1.00 | 1.00 |
EGF (10ng/ml) | 3.27 | - | - |
Ca2 + (3mM) | - | 2.01 | 3.60 |
제조예 1 (0.1%) | 1.51 | 1.73 | 1.82 |
제조예 2 (0.1%) | 1.12 | 1.23 | 1.18 |
제조예 3 (0.1%) | 1.09 | 1.11 | 1.04 |
제조예 4 (0.1%) | 1.15 | 1.13 | 1.09 |
제조예 5 (0.1%) | 1.21 | 1.28 | 1.26 |
제조예 6 (0.1%) | 1.05 | 1.09 | 1.10 |
제조예 7 (0.1%) | 1.51 | 1.64 | 1.69 |
제조예 8 (0.1%) | 1.42 | 1.53 | 1.56 |
제조예 9 (0.1%) | 2.75 | 2.93 | 2.96 |
Claims (10)
- 철피석곡(Dendrobium candidum) 꽃 추출물을 유효성분으로 포함하는 화장료 조성물.
- 제1항에 있어서, 상기 화장료 조성물은 주름 개선용인 것인, 화장료 조성물.
- 제1항에 있어서, 상기 화장료 조성물은 피부 미백용인 것인, 화장료 조성물.
- 제1항에 있어서, 상기 화장료 조성물은 피부 트러블 개선용인 것인, 화장료 조성물.
- 제1항에 있어서, 상기 화장료 조성물은 피부 보습용인 것인, 화장료 조성물.
- 제1항 내지 제5항 중 어느 한 항에 있어서, 상기 조성물은 콜라겐 합성 촉진, 멜라닌 생성 저해, 항염증 효과, 또는 보습 효과를 가지는 것인, 화장료 조성물.
- 철피석곡(Dendrobium candidum) 꽃 추출물을 유효성분으로 포함하는 의약외품 조성물.
- 제7항에 있어서, 상기 의약외품 조성물은 주름 개선용, 피부 미백용, 피부 트러블 개선용, 또는 피부 보습용인 것인, 의약외품 조성물.
- 철피석곡(Dendrobium candidum) 꽃 추출물을 유효성분으로 포함하는 식품 조성물.
- 제9항에 있어서, 상기 식품 조성물은 주름 개선용, 피부 미백용, 피부 트러블 개선용, 또는 피부 보습용인 것인, 식품 조성물.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020512863A JP7076534B2 (ja) | 2017-09-04 | 2018-07-11 | 鉄皮石斛(デンドロビウム・カンディダム)花の抽出物を含む化粧料組成物 |
CN201880057146.6A CN111093621A (zh) | 2017-09-04 | 2018-07-11 | 包含铁皮石斛花提取物的化妆料组合物 |
US16/644,101 US20210059927A1 (en) | 2017-09-04 | 2018-07-11 | Cosmetic composition comprising dendrobium candidum flower extract |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2017-0112585 | 2017-09-04 | ||
KR1020170112585A KR102126469B1 (ko) | 2017-09-04 | 2017-09-04 | 철피석곡 꽃 추출물을 포함하는 화장료 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2019045259A2 true WO2019045259A2 (ko) | 2019-03-07 |
WO2019045259A3 WO2019045259A3 (ko) | 2019-04-18 |
Family
ID=65525859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2018/007832 WO2019045259A2 (ko) | 2017-09-04 | 2018-07-11 | 철피석곡 꽃 추출물을 포함하는 화장료 조성물 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20210059927A1 (ko) |
JP (1) | JP7076534B2 (ko) |
KR (1) | KR102126469B1 (ko) |
CN (1) | CN111093621A (ko) |
WO (1) | WO2019045259A2 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111228197A (zh) * | 2020-04-01 | 2020-06-05 | 广州今盛美精细化工有限公司 | 一种铁皮石斛提取物及其在制备化妆品中的应用 |
WO2022129763A1 (fr) * | 2020-12-18 | 2022-06-23 | L V M H Recherche | Extrait de dendrobium fimbriatum et composition cosmétique non rincée en comprenant |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112438913A (zh) * | 2020-12-02 | 2021-03-05 | 周顺桂 | 一种延缓衰老的长白山灵芝孢子粉润肤油及其制作方法 |
KR102362106B1 (ko) | 2021-03-19 | 2022-02-14 | 주식회사 현대바이오랜드 | 철피석곡 꽃 발효물의 제조방법 및 상기 발효물을 포함하는 화장료 조성물 |
CN113425663A (zh) * | 2021-08-18 | 2021-09-24 | 皖西学院 | 一种石斛花大豆美肤面膜的制备方法 |
KR102606728B1 (ko) | 2021-08-18 | 2023-11-24 | 주식회사 현대바이오랜드 | 철피석곡 꽃으로부터 분리된 바실러스 시아멘시스 hdb8077 균주 및 이의 철피석곡 꽃 배양물을 함유하는 헤어케어 화장료 조성물 |
CN113893216A (zh) * | 2021-10-14 | 2022-01-07 | 安徽中美生谷生物科技有限公司 | 一种具有美白功效的组合物及其制备方法 |
CN115300580A (zh) * | 2022-04-25 | 2022-11-08 | 捷通国际有限公司 | 用于抑制晚期糖化终产物的组合物和方法 |
CN114796073B (zh) * | 2022-05-05 | 2024-08-06 | 浙江工业大学 | 一种抗衰除皱的铁皮石斛精华液及其制备方法和应用 |
CN114886813B (zh) * | 2022-05-27 | 2023-04-18 | 广州环亚化妆品科技股份有限公司 | 一种抗衰老的植物提取组合物及其制备方法和应用 |
CN115607486B (zh) * | 2022-07-29 | 2024-07-09 | 无限极(中国)有限公司 | 一种具有保湿修复美白功能的组合物及其应用 |
CN115251377A (zh) * | 2022-08-08 | 2022-11-01 | 江西省农业科学院农产品加工研究所 | 一种铁皮石斛速溶食品及其制备方法 |
CN115634187B (zh) * | 2022-12-26 | 2023-03-31 | 云南英格生物技术有限公司 | 铁皮石斛花提取物及制备方法和应用、铁皮石斛花提取液及应用、舒缓面霜及制备方法 |
CN116509777B (zh) * | 2023-02-14 | 2024-01-12 | 太和康美(北京)中医研究院有限公司 | 保湿组合物及其制备方法和应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000154113A (ja) | 1998-11-18 | 2000-06-06 | Ichimaru Pharcos Co Ltd | 保湿性植物抽出物を含有する化粧料組成物 |
KR20020044266A (ko) * | 2000-12-05 | 2002-06-15 | 양봉철 | 복합생약 추출물을 포함하는 피부 보호용 화장료 조성물 |
CN103168841B (zh) * | 2013-03-05 | 2014-11-26 | 蚌埠市福淋乳业有限公司 | 一种薰衣草保健酸奶 |
KR101570847B1 (ko) * | 2013-08-13 | 2015-11-20 | 주식회사 한국화장품제조 | 조직배양한 덴드로비움 칸디둠 다신초 추출물을 포함하는 화장료 조성물 |
CN103734383A (zh) * | 2013-12-18 | 2014-04-23 | 广西健宝石斛有限责任公司 | 一种铁皮石斛花养颜茶 |
CN104286272A (zh) * | 2014-10-28 | 2015-01-21 | 王春红 | 铁皮石斛花的用途及其茶叶制品 |
CN106692692A (zh) * | 2015-08-21 | 2017-05-24 | 中国科学院昆明植物研究所 | 一种铁皮石斛提取物及其制备方法 |
CN105219558A (zh) * | 2015-10-19 | 2016-01-06 | 西林县大银子铁皮石斛种销农民专业合作社 | 一种铁皮石斛美容皂及其制作方法 |
CN105640870B (zh) * | 2016-03-02 | 2018-12-07 | 名臣健康用品股份有限公司 | 一种含酵母提取物的皮肤护理组合物及皮肤护理产品 |
CN105534831B (zh) | 2016-03-17 | 2019-04-05 | 易智彪 | 一种具有保湿功效的铁皮石斛叶提取物及其在制备护肤品中的应用 |
CN105919897A (zh) * | 2016-06-21 | 2016-09-07 | 陆锦满 | 一种铁皮石斛提取液制备的爽身液 |
CN107519103A (zh) * | 2016-08-09 | 2017-12-29 | 浙江铁枫堂生物科技股份有限公司 | 一种用铁皮石斛为主要原料生产的化妆品新配方 |
CN106306260A (zh) * | 2016-08-30 | 2017-01-11 | 广西壮族自治区农业科学院花卉研究所 | 一种铁皮石斛花分类干燥方法 |
CN106359607A (zh) * | 2016-08-31 | 2017-02-01 | 福建永耕农业开发有限公司 | 一种铁皮石斛养生饮料及其制备方法 |
CN106727148A (zh) * | 2016-12-30 | 2017-05-31 | 广东国方医药科技有限公司 | 一种铁皮石斛补水修复面膜及其制备方法 |
CN107029115A (zh) * | 2017-03-30 | 2017-08-11 | 温岭市锦华铁皮石斛有限公司 | 一种天然防脱育发石斛花油 |
CN107158240A (zh) * | 2017-04-18 | 2017-09-15 | 温岭市锦华铁皮石斛有限公司 | 一种具有美白功效的铁皮石斛花提取物 |
-
2017
- 2017-09-04 KR KR1020170112585A patent/KR102126469B1/ko active IP Right Grant
-
2018
- 2018-07-11 WO PCT/KR2018/007832 patent/WO2019045259A2/ko active Application Filing
- 2018-07-11 CN CN201880057146.6A patent/CN111093621A/zh active Pending
- 2018-07-11 US US16/644,101 patent/US20210059927A1/en not_active Abandoned
- 2018-07-11 JP JP2020512863A patent/JP7076534B2/ja active Active
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111228197A (zh) * | 2020-04-01 | 2020-06-05 | 广州今盛美精细化工有限公司 | 一种铁皮石斛提取物及其在制备化妆品中的应用 |
WO2022129763A1 (fr) * | 2020-12-18 | 2022-06-23 | L V M H Recherche | Extrait de dendrobium fimbriatum et composition cosmétique non rincée en comprenant |
FR3117870A1 (fr) * | 2020-12-18 | 2022-06-24 | L V M H Recherche | Extrait deDendrobium fimbriatum et composition cosmétique non rincée en comprenant |
Also Published As
Publication number | Publication date |
---|---|
WO2019045259A3 (ko) | 2019-04-18 |
US20210059927A1 (en) | 2021-03-04 |
JP7076534B2 (ja) | 2022-05-27 |
JP2020532560A (ja) | 2020-11-12 |
KR20190026175A (ko) | 2019-03-13 |
KR102126469B1 (ko) | 2020-06-24 |
CN111093621A (zh) | 2020-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2019045259A2 (ko) | 철피석곡 꽃 추출물을 포함하는 화장료 조성물 | |
WO2014116022A1 (ko) | 레스베라트롤 유도체의 피부미백 용도 | |
WO2013129723A1 (en) | Composition for improving skin conditions comprising hordenine | |
WO2020218781A1 (ko) | 불멸화 줄기세포 유래 엑소좀 풍부 배양액 및 장미꽃봉오리 추출물을 유효성분으로 포함하는 기능성 조성물 | |
WO2024049120A1 (ko) | 친환경 천연 공융 용매로 추출한 추출물을 포함하는 화장료 조성물 | |
WO2020076101A1 (ko) | 시지지움 포르모슘 추출물을 유효성분으로 포함하는 피부 미백, 항균 또는 항아토피 조성물 | |
WO2019098468A1 (ko) | 양태반 분말과 식물의 복합물을 함유하는 피부 미백용, 피부 보습용 또는 피부주름 개선용 식품 또는 화장료 조성물 | |
WO2015156439A1 (ko) | 천심련추출물 또는 안드로그라폴라이드 또는 이의 염을 포함하는 피부상태 개선용 조성물 | |
WO2022260454A1 (ko) | 장수만리화 추출물을 포함하는 아토피 피부염 치료용 또는 피부 장벽 강화용 또는 노화 방지용 조성물 | |
WO2018111042A2 (ko) | 한약재 추출물을 유효성분으로 포함하는 화장료 조성물 | |
WO2020071630A1 (ko) | 천연소재 추출물을 포함하는 피부 개선용 조성물 | |
WO2022191339A1 (ko) | 송어에서 분리된 pdrn과 난포액을 포함하는 화장료 조성물 | |
WO2016159580A1 (ko) | 티아사포제놀 유도체를 유효성분으로 포함하는 조성물 | |
WO2016093515A1 (ko) | 장수 유전자 활성화용 조성물 | |
WO2019031790A1 (ko) | 세라마이드, 이의 유도체 및 목근피 추출물을 함유하는 피부 외용제 조성물 | |
WO2017138692A1 (ko) | 어리연꽃 속 식물의 추출물을 포함하는 피부 개선용 화장료 조성물 | |
WO2016017894A1 (ko) | 밭벼 추출물을 포함하는 화장료 조성물 및 이의 제조방법 | |
KR102105672B1 (ko) | 용안육 추출물을 포함하는 화장료 조성물 | |
KR20180090123A (ko) | 리퀴댐버릭 락톤을 포함하는 화장료 조성물 | |
WO2019132217A1 (ko) | 회화나무열매 발효액 또는 이의 추출액을 유효성분으로 함유하는 피부 주름개선용 화장료 조성물 및 그의 제조방법 | |
EP3549574B1 (en) | Composition for promoting hair growth or hair restoration, containing novel pantetheine-based substance | |
WO2017003190A1 (ko) | 백심 뿌리 추출물을 포함하는 미백용 화장료 조성물 | |
WO2019013365A1 (ko) | 개미취속 식물의 추출물을 유효성분으로 포함하는 항노화용 조성물 | |
KR101176524B1 (ko) | 플라보노이드계 화합물을 유효 성분으로 함유하는 피부 노화 방지용 화장료 조성물 | |
WO2024010355A1 (ko) | 고소리술 술지게미 추출물을 포함하는 항노화용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18850173 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2020512863 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18850173 Country of ref document: EP Kind code of ref document: A2 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 01.02.2021) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18850173 Country of ref document: EP Kind code of ref document: A2 |